$2.61T
Total marketcap
$169.03B
Total volume
BTC 50.02%     ETH 15.80%
Dominance

Insmed Incorporated INSM Stock

26.14 USD {{ price }} 1.632971% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
3.88B USD
LOW - HIGH [24H]
25.52 - 26.41 USD
VOLUME [24H]
2.14M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-5.34 USD

Insmed Incorporated Price Chart

Insmed Incorporated INSM Financial and Trading Overview

Insmed Incorporated stock price 26.14 USD
Previous Close 19.29 USD
Open 19.28 USD
Bid 0 USD x 1000
Ask 0 USD x 1000
Day's Range 19.01 - 20.02 USD
52 Week Range 16.04 - 28.94 USD
Volume 820.01K USD
Avg. Volume 1.07M USD
Market Cap 2.73B USD
Beta (5Y Monthly) 1.526408
PE Ratio (TTM) N/A
EPS (TTM) -5.34 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 39.42 USD

INSM Valuation Measures

Enterprise Value 2.97B USD
Trailing P/E N/A
Forward P/E -4.7082353
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 10.6034775
Price/Book (mrq) N/A
Enterprise Value/Revenue 11.528
Enterprise Value/EBITDA -5.632

Trading Information

Insmed Incorporated Stock Price History

Beta (5Y Monthly) 1.526408
52-Week Change 7.69%
S&P500 52-Week Change 20.43%
52 Week High 28.94 USD
52 Week Low 16.04 USD
50-Day Moving Average 18.79 USD
200-Day Moving Average 19.68 USD

INSM Share Statistics

Avg. Volume (3 month) 1.07M USD
Avg. Daily Volume (10-Days) 825.54K USD
Shares Outstanding 136.43M
Float 134.67M
Short Ratio 8.89
% Held by Insiders 1.12%
% Held by Institutions 107.83%
Shares Short 9.01M
Short % of Float 6.71%
Short % of Shares Outstanding 6.61%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -212.33%
Operating Margin (ttm) -207.53%
Gross Margin 77.95%
EBITDA Margin -204.68%

Management Effectiveness

Return on Assets (ttm) -25.0060%
Return on Equity (ttm) -1453.40%

Income Statement

Revenue (ttm) 257.46M USD
Revenue Per Share (ttm) 2.02 USD
Quarterly Revenue Growth (yoy) 22.80%
Gross Profit (ttm) 190.23M USD
EBITDA -526979008 USD
Net Income Avi to Common (ttm) -546676992 USD
Diluted EPS (ttm) -4.25
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 998.68M USD
Total Cash Per Share (mrq) 7.32 USD
Total Debt (mrq) 1.33B USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 6.006
Book Value Per Share (mrq) -0.327

Cash Flow Statement

Operating Cash Flow (ttm) -441580992 USD
Levered Free Cash Flow (ttm) -238658000 USD

Profile of Insmed Incorporated

Country United States
State NJ
City Bridgewater
Address 700 US Highway 202/206
ZIP 08807
Phone 908 977 9900
Website https://www.insmed.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 736

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis, and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Q&A For Insmed Incorporated Stock

What is a current INSM stock price?

Insmed Incorporated INSM stock price today per share is 26.14 USD.

How to purchase Insmed Incorporated stock?

You can buy INSM shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Insmed Incorporated?

The stock symbol or ticker of Insmed Incorporated is INSM.

Which industry does the Insmed Incorporated company belong to?

The Insmed Incorporated industry is Biotechnology.

How many shares does Insmed Incorporated have in circulation?

The max supply of Insmed Incorporated shares is 148.49M.

What is Insmed Incorporated Price to Earnings Ratio (PE Ratio)?

Insmed Incorporated PE Ratio is now.

What was Insmed Incorporated earnings per share over the trailing 12 months (TTM)?

Insmed Incorporated EPS is -5.34 USD over the trailing 12 months.

Which sector does the Insmed Incorporated company belong to?

The Insmed Incorporated sector is Healthcare.

Insmed Incorporated INSM included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Biotechnology Total Retu XNBI 4654.3 USD
-0.65
4652.69 USD 4696.7 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD